glp 1 api GLP-1 Agonists and Antagonists Liraglutide API for Obesity and

Multiple reviewers praised the guidance received from their doctors, nutritionist support and affordability

doi: 10.1210/jc.2013-3644 [DOI] [PubMed] [Google Scholar] 50.De Block C, Bailey C, Wysham C, et al

Wegovy (semaglutide) Manufacturer: Novo Nordisk What It Is : Wegovy, similar to Ozempic, is a higher-dose injectable form of semaglutide approved specifically for chronic weight management in adults with obesity or who are overweight with weight-related conditions

Electrolyte imbalance can also trigger headaches

While this change has not been associated with increased cardiovascular events, it may warrant monitoring in individuals with underlying cardiac conditions (29)